Compare DSWL & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DSWL | ICCC |
|---|---|---|
| Founded | 1987 | 1982 |
| Country | Macau | United States |
| Employees | N/A | N/A |
| Industry | Plastic Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.7M | 55.5M |
| IPO Year | 2000 | 1995 |
| Metric | DSWL | ICCC |
|---|---|---|
| Price | $3.61 | $6.50 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 11.9K | ★ 19.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 5.56% | N/A |
| EPS Growth | N/A | ★ 65.33 |
| EPS | N/A | ★ 0.20 |
| Revenue | N/A | ★ $26,493,169.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $4.59 | $32.10 |
| Revenue Growth | N/A | ★ 51.64 |
| 52 Week Low | $2.03 | $4.32 |
| 52 Week High | $4.48 | $7.60 |
| Indicator | DSWL | ICCC |
|---|---|---|
| Relative Strength Index (RSI) | 58.16 | 57.42 |
| Support Level | $3.52 | $6.20 |
| Resistance Level | $3.68 | $6.78 |
| Average True Range (ATR) | 0.14 | 0.25 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 84.09 | 89.32 |
Deswell Industries Inc is engaged in the manufacturing and selling of injection-molded plastic parts and components. In addition, it also offers manufacturing services for electronic products and subassemblies and manufactures metallic molds and accessory parts for original equipment manufacturers and contract manufacturers. The company conducts all of its manufacturing activities at separate plastics, electronics and metallic operation factories located in the People's Republic of China. It operates through the Plastic Injection Molding and Electronic Products Assembling segments. The firm offers products such as automobile components, medical testing equipment, parts for audio equipment, av receivers, active subwoofers, digital system key sets, communication products and others.
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.